Patagonia Pharmaceuticals, LLC is a clinical stage, privately owned, New Jersey based pharmaceutical company founded in 2013. The company focuses on developing innovative prescription therapies to address unmet medical needs for rare dermatologic diseases. Their primary industries are Biotechnology and Pharmaceutical. Despite not having publicly disclosed information regarding their last investment and the associated investors, Patagonia Pharmaceuticals, LLC stands as a promising venture for potential investment opportunities in the biotech and pharmaceutical sectors.
There is no investment information
We care about your data, and we'd love to use cookies make your experience better.